FormDSignal
55

Dravite Therapeutics, Inc. raises $53M under Reg D

Company raise · Closed · SAN FRANCISCO, CA · Form D filed 2026-09-03
$50M+ raise

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

RISHI GUPTADirector
MATTHEW MOOREExecutive Officer, Director
JOSEPH SUMExecutive Officer, Director
BARBARA KOSACZDirector
SANDEEP KULKARNIDirector
JEREMY GOLDBERGDirector

Signed by Matthew Moore, President and CEO.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer